Supply of Generic Pharmaceuticals to NHS England under National Framework Agreement

About

NHS England awarded a contract to Pfizer Ltd, Accord-UK Ltd, Amarox Limited, Ascend Laboratories UK Ltd, Aspen Pharma Ireland Limited, Aspire Pharma Limited, Aventis Pharma ltd t/a Sanofi, Brown & Burk UK Ltd, Day Lewis Medical Ltd, and Dr.

Reddy's for the supply of generic pharmaceuticals under the National Generic Pharmaceuticals Transition 2021_1 framework agreement.

The framework agreement has a total maximum duration of up to 29 months, comprising an initial 14.5-month period plus options to extend for a further 14.5 months at the Authority's sole discretion.

Call-offs under the framework cover Transition and 33% Products for CESW (15 April 2021 to 30 September 2021), LSNE (15 April 2021 to 28 February 2022), and NWLN (15 April 2021 to 30 June 2022), as well as 100% Products for all regions (15 April 2021 to 28 February 2022).

The contract value is AUD 8,858,050.